• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bioadaptives Inc (OP:BDPT)

    0.0074 -0.0006 (-7.50%)
    Streaming Delayed Price Updated: 11:14 AM EDT, Jun 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,755,161
    Open 0.0071
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0080
    Today's Range 0.0050 - 0.0074
    52wk Range 0.0068 - 0.0900
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — BioAdaptives, Inc. (OTC: BDPT) Launches MyndSystem Cognitive Support Platform
    Via Investor Brand Network
    InvestorNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Launches MyndRenew Nighttime Supplement for Cognitive Recovery
    Via Investor Brand Network

    Performance

    YTD
    -66.4%
    -66.4%
    1 Month
    -22.1%
    -22.1%
    3 Month
    -50.7%
    -50.7%
    6 Month
    -69.5%
    -69.5%
    1 Year
    -87.9%
    -87.9%

    More News

    Read More
    InvestorNewsBreaks – BioAdaptives, Inc. (OTCMKTS: BDPT) Launches MyndSystem Platform and Website for Cognitive Performance and Recovery
    Via Investor Brand Network
    NetworkNewsBreaks – BioAdaptives, Inc. (OTCMKTS: BDPT) Launches MyndMed Cognitive-Support Supplement Following Successful Testing and Strong Early Demand
    Via Investor Brand Network
    InvestorNewsBreaks – BioAdaptives, Inc. (OTCMKTS: BDPT) Launches MyndMed Cognitive-Support Supplement Following Successful Testing and Strong Early Demand
    Via Investor Brand Network
    BioMedNewsBreaks — BioAdaptives, Inc. (OTCMKTS: BDPT) Receives WADA-Compliant Certification for MyndMed(TM) From TruShield(TM)
    Via Investor Brand Network
    InvestorNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025
    Via Investor Brand Network
    InvestorNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum
    Via Investor Brand Network
    News headline image
    BioAdaptives Announces National Launch of Pawpa™ Regen
    From BioAdaptives Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Bioadaptives Inc (BDPT) Showcases Breakthrough Stem Cell Benefits in Regen Dog Chews
    Via Investor Brand Network
    News headline image
    InvestorNewsBreaks – Bioadaptives Inc (BDPT) Completes Successful Dosage Trials for Zeranovia™ Weight Loss Product
    Via Investor Brand Network
    BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Announces Board Appointment of UFC Senior Executive Reed Harris
    Via Investor Brand Network
    BioMedNewsBreaks — BioAdaptives Inc. (BDPT) Announces Board Appointment of Visionary Leader Mark Frissora
    Via Investor Brand Network
    BioMedNewsBreaks — BioAdaptives Inc. (BDPT) Announces Dividend for Common Stock Shareholders
    Via Investor Brand Network
    BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Launches Xcellara(TM) — an Innovative Supplement That Harnesses Nature for Optimal Health
    Via Investor Brand Network
    InvestorNewsBreaks — BioAdaptives Inc. (BDPT) Announces One-for-One Stock Dividend
    Via Investor Brand Network
    BioMedNewsBreaks — BioAdaptives Inc. (BDPT) to Proceed with Human Clinical Trial for Zeranovia(TM)
    Via Investor Brand Network
    BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Unveils New Suite of Next-Gen Nutritional Products
    Via Investor Brand Network
    InvestorNewsBreaks – BioAdaptives, Inc. (BDPT) Appoints Car Rental Industry Veteran to Its Board of Directors
    Via Investor Brand Network
    News headline image
    BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives
    Via NewMediaWire
    BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives
    Via TheNewswire.com
    BioAdaptives, Inc. Announces NaturaComplete, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
    Via NewMediaWire
    Topics Artificial Intelligence
    News headline image
    BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
    Via NewMediaWire
    Topics Artificial Intelligence
    BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
    Via TheNewswire.com
    Topics Artificial Intelligence
    BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products
    Via NewMediaWire
    Topics Retirement

    Frequently Asked Questions

    Is Bioadaptives Inc publicly traded?
    Yes, Bioadaptives Inc is publicly traded.
    What exchange does Bioadaptives Inc trade on?
    Bioadaptives Inc trades on the OTC Traded
    What is the ticker symbol for Bioadaptives Inc?
    The ticker symbol for Bioadaptives Inc is BDPT on the OTC Traded
    What is the current price of Bioadaptives Inc?
    The current price of Bioadaptives Inc is 0.0074
    When was Bioadaptives Inc last traded?
    The last trade of Bioadaptives Inc was at 06/03/26 11:14 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.